NASDAQ$ALKS

Alkermes plc · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

Alkermes reported financial results for the fourth quarter and year ended December 31, 2023, and provided financial expectations for 2024.

Alkermes reported Q4 2023 financial results, with total revenues of $377.5 million. The company's proprietary product net sales increased year-over-year. GAAP net income for the quarter was $112.8 million. The company provided financial expectations for 2024, including generating a 30% EBITDA margin.

  • Total revenues for Q4 2023 were $377.5 million.
  • GAAP net income for Q4 2023 was $112.8 million.
  • The company expects to generate a 30% EBITDA margin in 2024.
  • LYBALVI revenues for the fourth quarter grew 61% compared to Q4 2022.

Headline financials

Total Revenue

$377M

Previous: $305M+23.9%
EPS (adj)

$0.48

Previous: $0.14+242.9%
Capital Expenditures

$17M

Previous: $10M+69.8%
Net Income

$113M

Previous: -$28.3M+498.5%
Operating Income

$54.6M

Previous: -$20.6M+365.4%
Gross Profit

$298M

Previous: $251M+19.0%
R&D Expense

$73.9M

No prior period
Stock-Based Comp

$25.8M

Previous: $26.5M-2.4%

Revenue & EPS history

Alkermes · Revenue · Quarterly

$377M

Q4 2023+23.9%vs Q4 2022
Beat estimate in 11 of 15 quarters(73%)
ActualEstimate

Revenue by segment

Alkermes · $232M total across 3 segments · Q3 2023

  • VIVITROL
    $99.3M+2.9%
  • ARISTADA
    $81.8M+8.1%
  • LYBALVI
    $50.7M+87.1%

Forward guidance

Alkermes provided financial expectations for 2024.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

-0.6%

Avg return

Earnings day

-0.0%

Avg return

5 days after

-0.5%

Avg return

30 days after

45%

27 / 60 earnings

Positive

+16.6%

Q4 2017

Best reaction

-14.8%

Q1 2020

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+6.2%+2.5%+27.0%
Q4 2025-6.6%-9.4%-12.0%
Q3 2025+3.9%+3.3%+0.0%
Q1 2025+6.3%+5.5%+6.4%
Q4 2024+4.8%+12.3%+6.5%
Q3 2024-6.3%-5.1%+3.3%
Q2 2024+12.2%+11.7%+11.8%
Q1 2024-2.8%-1.8%-4.6%
Q4 2023+15.0%+8.6%+2.7%
Q3 2023-2.4%-4.0%-3.7%
Q2 2023-1.8%-5.1%-11.9%
Q1 2023-7.1%-6.1%-3.9%
Q4 2022+4.0%+2.9%-3.6%
Q3 2022+3.8%+0.3%+12.2%
Q2 2022-9.7%-14.4%-16.5%
Q1 2022+9.8%+6.4%+12.5%
Q4 2021+8.8%+7.6%+12.1%
Q3 2021-8.2%-5.0%-28.7%
Q2 2021+5.9%+11.6%+28.9%
Q1 2021-3.2%-1.6%+0.8%
Q4 2020-11.8%-13.7%-15.3%
Q3 2020+5.6%+5.9%+20.2%
Q2 2020-8.8%-7.4%-19.0%
Q1 2020-14.8%-14.7%+1.6%
Q4 2019-7.0%-7.8%-15.5%
Q3 2019+5.7%+6.0%+13.9%
Q2 2019-10.2%+1.2%-12.3%
Q1 2019-12.2%-12.7%-31.1%
Q4 2018-1.2%+3.6%+3.3%
Q3 2018+3.0%+6.5%-11.6%
Q2 2018-0.1%-0.3%+2.0%
Q1 2018+1.5%+1.4%+3.9%
Q4 2017+16.6%+23.0%+12.0%
Q3 2017+0.7%-1.5%+3.2%
Q2 2017-4.1%-5.4%-12.4%
Q1 2017+2.0%+2.4%+1.0%
Q4 2016-2.9%-4.6%+3.7%
Q3 2016-1.4%+4.0%+8.4%
Q2 2016-3.6%-6.0%-14.1%
Q1 2016-2.0%
Q4 2015-1.4%
Q3 2015+7.6%
Q2 2015+2.4%
Q1 2015+3.1%
Q4 2014-3.4%
Q3 2014+7.7%
Q2 2014-7.2%
Q1 2014+3.2%
Q4 2013-7.7%
Q3 2013-3.7%
Q2 2013+3.5%
Q1 2013+3.9%
Q4 2010-1.0%
Q4 2012-9.9%
Q3 2012+2.2%
Q3 2011+2.2%
Q2 2011-7.7%
Q2 2012-7.7%
Q4 2011-7.7%
Q2 2010-3.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro